During the past decade, Praxisgemeinschaft Frauenärzte am Bahnhofsplatz conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Praxisgemeinschaft Frauenärzte am Bahnhofsplatz" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "AGO Research GmbH" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "North Eastern German Society of Gynaecological Oncology" with 1 trials sponsored and "Prof. Wolfgang Janni" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxisgemeinschaft Frauenärzte am Bahnhofsplatz" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Center for Clinical Trials Philipps University Marburg" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Praxisgemeinschaft Frauenärzte am Bahnhofsplatz" are "Breast Cancer" (2 trials), "Breast Tumor" (1 trials), "Cancer of the Breast" (1 trials), "Estrogen Receptor Positive Tumor" (1 trials) and "Estrogen Receptor- Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Praxisgemeinschaft Frauenärzte am Bahnhofsplatz" in a lesser frequency.

Most popular intervention types in "Praxisgemeinschaft Frauenärzte am Bahnhofsplatz" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "5-Fluorouracil" (1 trials), "Abemaciclib + Aromatase Inhibitor" (1 trials) and "Abemaciclib + Fulvestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Praxisgemeinschaft Frauenärzte am Bahnhofsplatz" are 4 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Praxisgemeinschaft Frauenärzte am Bahnhofsplatz". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Praxisgemeinschaft Frauenärzte am Bahnhofsplatz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxisgemeinschaft Frauenärzte am Bahnhofsplatz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".